Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to PSYCHOPHARMACOLOGY

Psych Congress Network

Mebufotenin Shows Rapid Antidepressant Effects in Phase 2b Trial

Psychiatric Pharmacy (BCPP) November 20th 2026

News Medical

Psilocybin Reshapes Brain Connections Through Distinct Cellular Pathways

Clinical Pharmacology November 10th 2026

Medical Professionals Reference (MPR)

Once-Monthly Weltruza Approved for Schizophrenia

Behavioral Health October 20th 2026

Psychiatrist.com

Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression: A Phase 2a Open-Label Clinical Trial

Clinical Pharmacology October 9th 2026

Psychiatrist.com

The Prescriber’s Guide to Oral Ketamine for Patients With Major Depressive Illness: Principles and Practice

Behavioral Health September 25th 2026

Psychiatrist.com

When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?

Behavioral Health September 4th 2026

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form